(Q35744476)

10 August 2017

1 reference

title

Chronic hepatitis in dogs: a review of current understanding of the aetiology, progression, and treatment (English)

1 reference

10 August 2017

1 reference

Watson PJ

1

1 reference

10 August 2017

publication date

1 May 2004

1 reference

10 August 2017

published in

The Veterinary Journal

1 reference

10 August 2017

volume

167

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

228-241

1 reference

Chronic hepatitis associated with leptospiral infection in vaccinated beagles

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Accuracy of hepatic adverse drug reaction reporting in one English health region

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Hepatic stellate cells as a target for the treatment of liver fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Autoimmune hepatitis and its variant syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Lobular dissecting hepatitis in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Is liver fibrosis reversible?

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

The pharmacokinetics of penicillamine in a female mongrel dog

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Naturally acquired leptospirosis in 36 dogs: serological and clinicopathological features

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Characterization of the inflammatory infiltrate in canine chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Hepatotoxicity associated with pharmacologic agents in dogs and cats

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Nutritional support for dogs and cats with hepatobiliary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Chronic liver disease: current concepts of disease mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Liver glutathione concentrations in dogs and cats with naturally occurring liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Use of polymerase chain reaction and immunohistochemistry for detection of canine adenovirus type 1 in formalin-fixed, paraffin-embedded liver of dogs with chronic hepatitis or cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Virus-like particles in serum of patients with Australia-antigen-associated hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Helicobacter canis isolated from a dog liver with multifocal necrotizing hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Treatment of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

A classification of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Detection of mammalian and avian hepadnaviruses by the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Hepatitis and copper accumulation in Skye terriers

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

An overview of proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

DNA marker C04107 for copper toxicosis in a population of Bedlington terriers in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Spontaneous familial systemic lupus erythematosus in a canine breeding colony

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

A new transmissible agent causing acute hepatitis, chronic hepatitis and cirrhosis in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Persistent hepatitis and chronic fibrosis induced by canine acidophil cell hepatitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Technetium 99m sulfur colloid scintigraphy to evaluate reticuloendothelial system function in dogs with portasystemic shunts.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Colchicine myopathy and neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Pathophysiology and pharmacologic modulation of hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Recent advances: hepatology

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Diagnosis and management of hepatic copper accumulation in a Skye terrier.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Use of ursodeoxycholic acids in a dog with chronic hepatitis: effects on serum hepatic tests and endogenous bile acid composition

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Serum antibodies to Helicobacter hepaticus and Helicobacter pylori in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Cell-mediated immune responses to liver membrane protein in canine chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Familial glomerulonephropathy in a litter of beagles

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Effect of ursodeoxycholic acid on methionine adenosyltransferase activity and hepatic glutathione metabolism in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Copper-associated hepatopathies in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Diagnostic value of a microsatellite DNA marker for copper toxicosis in West-European Bedlington terriers and incidence of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Idiopathic hepatic fibrosis in 15 dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

ABC of diseases of liver, pancreas, and biliary system. Other causes of parenchymal liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Iatrogenic copper deficiency associated with long-term copper chelation for treatment of copper storage disease in a Bedlington Terrier

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Diagnosis and prognosis of chronic hepatitis and cirrhosis in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Hepatic accumulation of alpha-1-antitrypsin in chronic liver disease in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Lesions of subclinical doberman hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Growth-stimulating factor in regenerating canine liver

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Chronic hepatitis in the dog--a review

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Experimental model of extended repeated partial hepatectomy in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Histomorphological and immunohistochemical studies of chronic active hepatitis in Doberman Pinschers

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

A perspective on copper and liver disease in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

The relationship between hepatic copper content and morphologic changes in the liver of West Highland White Terriers

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Molecular pathogenesis of iron overload.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Association of hepatic necrosis with trimethoprim sulfonamide administration in 4 dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Lobular dissecting hepatitis in juvenile and young adult dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Chronic active hepatitis with cirrhosis in the Doberman Pinscher

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Identification of a new copper metabolism gene by positional cloning in a purebred dog population

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

Anti-liver membrane protein antibodies in dogs with chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1090-0233%2803%2900118-7

7 January 2021

10.1016/S1090-0233(03)00118-7

Identifiers

DOI

1 reference

10 August 2017

1 reference